Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill could tame Crohn's Flare-Ups

NCT ID NCT06456593

Disease control Sponsor: Abivax S.A. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an experimental oral drug called obefazimod in 212 adults with moderate-to-severe Crohn's disease who haven't responded well to other treatments. Participants receive either obefazimod or a placebo daily for 12 weeks (induction), then up to 40 more weeks (maintenance), followed by a 48-week extension. The goal is to see if the drug reduces inflammation and symptoms better than placebo, and to check its safety over the long term.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
obefazimod (a once-daily oral drug)
What this could lead to
If successful, obefazimod could offer a new oral treatment option to reduce inflammation and improve symptoms in people with moderate-to-severe Crohn's disease.
What could go wrong
This is a mid-stage (Phase 2b) trial with only 212 participants, so results may not confirm benefit. The drug may cause side effects or fail to outperform placebo.
Why investors are watching

Abivax is testing obefazimod in 212 patients with moderately to severely active Crohn's disease who have not responded to other treatments. This phase 2b readout will show whether the drug can control the disease during a 12-week induction phase and a 40-week maintenance phase. For a small company like Abivax, this trial is a key test of the drug's value beyond its existing use.

If it works: A positive result could support further development of obefazimod for Crohn's disease, expanding its potential market. It may also strengthen the company's position in inflammatory bowel disease treatments.

If it fails: The trial could fail to show that obefazimod works better than placebo, or safety issues could emerge. Clinical trials often fail, and a negative result would likely hurt the company's prospects for this drug.

AI-written from the trial record. Speculative, and not investment advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 212 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female (at birth) 18 to 75 years old and able to understand, sign, and date the written voluntary informed consent at the visit prior to any protocol-specified procedures 2. Able and willing to comply with study visits and procedures as per protocol. 3. Confirmed and documented diagnosis of CD based on endoscopy and histology reports. 4. Moderately to severely active CD as defined by 220 ≤ CDAI ≤ 450 and SES-CD ≥ 6 for ileo-colonic or colonic disease or SES-CD ≥ 4 for isolated ileal disease (per central reading). 5. Documented inadequate response (defined as lack of response or loss of response or intolerance) to at least one of the following treatments: corticosteroids (CS), immunosuppressants (IS), biologic or biosimilar therapies, or janus kinase (JAK) (note: failure to only 5-aminosalicylic acid \[5-ASA\] is not accepted) 6. Women of childbearing potential (WOCBP) and male subjects with WOCBP partner must agree to comply with contraception requirements as stated in section 4.5 (contraception) of this protocol. 7. Subject should be affiliated to a health insurance policy whenever required by a participating country or state. 8. Subject is able and willing to comply with usual public recommendations for sun protection. Exclusion Criteria: Subjects who meet any of the following exclusion criteria will be excluded from the study: 1. WOCBP subject who is pregnant or breast-feeding at screening, or intends to become pregnant during the study; or male subject with WOCBP partner who intends to be pregnant during the study. 2. Current diagnosis of ulcerative colitis (UC) or indeterminate colitis 3. CD without ileal and/or colonic involvement 4. Untreated active external or perianal fistula or abscess. Stable fistula without abscess and with minimal or low drainage may be enrolled. Recent cutaneous and perianal abscesses are not exclusionary if drained and adequately treated at least 3 weeks before screening colonoscopy or 8 weeks before screening colonoscopy for intra-abdominal abscesses, if no additional surgery is anticipated. 5. Symptomatic bowel stricture and/or stenosis not passable in endoscopy 6. Related to CD surgery: 1. Current stoma or ileoanal pouch 2. More than 2 missing complete segments of the following 5 segments: terminal ileum, right colon, transverse colon, left colon, and sigmoid and rectum 3. Combined previous small bowel resections \> 100 cm 4. Surgical bowel resection within the past 3 months prior to baseline 5. Any other manifestation that might require surgery while enrolled in the study 7. Related to CD treatments: 1. Subject who is currently treated with prohibited concomitant therapies for CD as described in the study protocol 2. Subject who has previously received natalizumab (or any other α4β1 integrin agonist) 3. Subject who has failed more than three advanced therapies for the treatment of CD, or two different mechanisms of action for advanced therapies of CD 8. History of, or active, malignancy including nonmelanoma skin cancer (subjects with a 5-year disease-free survival are eligible) 9. History of colonic cancer or colonic low grade or high grade dysplasia adenomatous polyps, and/or at the screening endoscopy, evidence of low grade or high grade dysplasia adenomatous polyps (fully removed or not) 10. Subject with history of, or diagnosed with, the following during screening: primary sclerosing cholangitis, autoimmune hepatitis, or primary biliary cirrhosis 11. Serious illness requiring hospitalization (not related to CD) within 4 weeks prior to screening 12. Subject with the following infectious conditions: 1. Chronic or recurrent Grade 3 or Grade 4 infection within the last 2 months prior to screening or history of opportunistic infection while not on immunosuppressive therapy 2. Herpes zoster reactivation within the last 2 months prior to screening 3. Active infection at screening or any major episode of infection that required hospitalization or treatment with IV antibiotics within 1 month of screening or during screening (fungal infection of nail beds is allowed) 4. Positive assay or stool culture for pathogens (ova and parasite examination, bacteria) that required treatment per local medical practice or positive test for Clostridioides difficile (C. difficile) toxin at screening. 5. Subject with human immunodeficiency virus (HIV) infection 6. Acute or chronic hepatitis B infection at screening (positive for hepatitis B surface antigen \[HbsAg\] or negative for HbsAg and positive for anti-hepatitis B core antibody in conjunction with detectable hepatitis B virus \[HBV\] deoxyribonucleic acid \[DNA\], or detectable HBV DNA). 7. Acute or chronic hepatitis C virus (HCV) infection as defined by positive for hepatitis C antibody (subjects successfully treated and without recurrence ≥ 1 year with no detectable HCV RNA \[assessed centrally\] are eligible) 8. Active tuberculosis (TB) or untreated latent TB (For subjects with positive or intermediate QuantiFERON test) 13. Subject with uncontrolled ischemic heart disease and/or a history of congestive heart failure 14. Subject with a known family or personal history of congenital or acquired long QT syndrome, or subjects with a marked baseline prolongation of QT/ heart rate-corrected QT (QTc) interval 15. Subject with a history of torsade de pointe (TdP) 16. Acute or chronic clinically relevant pulmonary, hepatic, or renal functional abnormality, encephalopathy, neuropathy or unstable central nervous system pathology such as seizure disorder, or any other clinically significant medical problems. 17. Subjects who received live vaccine within 3 months prior to screening and/or subject who is planning to receive such a vaccine during the study duration 18. Acute or chronic pancreatitis 19. Subject with the following hematological and biochemical laboratory parameters obtained during the screening period: 1. Hemoglobin ≤ 8.0 g/dL1 2. Absolute neutrophil count \< 750/mm3 3. Platelets \< 100,000 /mm3 4. eGFR \< 60 mL/min/1.73 m2 5. Total serum bilirubin \> 1.5 x ULN (except if related to pre-existing and documented Gilbert syndrome) 6. Aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) \> 2 x ULN 20. Subject who does not meet the washout period requirements prior to the screening endoscopy as described in the prohibited medication section of the study protocol 21. Use of any investigational or nonregistered product within 3 months or within 5 halflives preceding baseline, whichever is longer, and during the study. 22. Subjects previously treated with obefazimod or with a known hypersensitivity to the active substance or to any of the excipients 23. Illicit drug or alcohol abuse or dependence 24. Subject who is committed to an institution by virtue of an order issued either by the judicial or the administrative authorities 25. Any condition, which in the opinion of the investigator, could compromise the subject's safety or adherence to the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Moderately to severely active Crohn disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Moderately to severely active Crohn disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    149 sites in 12 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ALLMEDICA sp. z o. o.

    RECRUITING

    Nowy Targ, Poland

  • AMICARE spółka z ograniczoną odpowiedzialnością spółka komandytowa

    RECRUITING

    Lodz, Poland

  • AZ Maria Middelares

    RECRUITING

    Ghent, Belgium

  • Advanced Research Institute, Inc.

    RECRUITING

    New Port Richey, Florida, 34653, United States

  • Amsterdam UMC, Locatie AMC

    RECRUITING

    Amsterdam, Netherlands

  • Auzmer Research

    RECRUITING

    Lakeland, Florida, 33813, United States

  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS

    NOT_YET_RECRUITING

    Bologna, Italy

  • Azienda Ospedaliera Universitaria Renato Dulbecco di Catanzaro

    NOT_YET_RECRUITING

    Catanzaro, Italy

  • Baylor University Hospital

    RECRUITING

    Dallas, Texas, 75246, United States

  • Bekes Varmegyei Kozponti Korhaz

    RECRUITING

    Békéscsaba, Hungary

  • Bernhoven Uden

    NOT_YET_RECRUITING

    Uden, Netherlands

  • CHU Amiens

    RECRUITING

    Amiens, France

  • CHU Besançon - Hôpital Jean Minjoz

    NOT_YET_RECRUITING

    Besançon, France

  • CHU Bordeaux - Hôpital Haut-Lévêque

    RECRUITING

    Pessac, France

  • CHU Clermont Ferrand - Hopital d'Estaing

    RECRUITING

    Clermont-Ferrand, France

  • CHU Dijon - Hôpital Bocage Central

    NOT_YET_RECRUITING

    Dijon, France

  • CHU Lille - Hôpital Claude Huriez

    NOT_YET_RECRUITING

    Lille, France

  • CHU Nantes - Hôtel Dieu

    NOT_YET_RECRUITING

    Nantes, France

  • CHU Nice - Hôpital de l'Archet 2

    NOT_YET_RECRUITING

    Nice, France

  • CHU Saint Etienne - Hôpital Nord

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • CHU UCL Namur

    RECRUITING

    Yvoir, Belgium

  • CHU de Grenoble - Hôpital Michallon

    NOT_YET_RECRUITING

    Grenoble, France

  • Central Texas Clinical Research, LLC

    NOT_YET_RECRUITING

    Austin, Texas, 78705, United States

  • Centre Hospitalier Départemental Vendée - Les Oudairies

    NOT_YET_RECRUITING

    La Roche-sur-Yon, France

  • Centre Hospitalier Lyon Sud

    RECRUITING

    Pierre-Bénite, France

  • Centre Wallonie Picarde

    NOT_YET_RECRUITING

    Tournai, Belgium

  • Centro Medico Teknon

    RECRUITING

    Barcelona, Spain

  • Centrum Medyczne Medis

    RECRUITING

    Bydgoszcz, Poland

  • Centrum Medyczne Plejady

    RECRUITING

    Krakow, Poland

  • Centrum Zdrowia MDM

    RECRUITING

    Warsaw, Poland

  • Charite-Campus Benjamin Franklin Medizin.Klin.I

    NOT_YET_RECRUITING

    Berlin, Germany

  • Clinfan Szolgaltato Kft.

    NOT_YET_RECRUITING

    Szekszárd, Hungary

  • Clinica Gaias - Santiago

    RECRUITING

    Santiago de Compostela, Spain

  • Clinical Research Of Brandon, LLC

    RECRUITING

    Brandon, Florida, 33511, United States

  • Cliniq s.r.o.

    RECRUITING

    Bratislava, Slovakia

  • DC-MED

    RECRUITING

    Swidnica, Poland

  • Dartmouth-Hitchcock Medical Center

    NOT_YET_RECRUITING

    Lebanon, New Hampshire, 03756, United States

  • ETG Zamosc

    NOT_YET_RECRUITING

    Zamość, Poland

  • ETZ Elisabeth

    RECRUITING

    Tilburg, Netherlands

  • Endomed, s.r.o.

    RECRUITING

    Košice, Slovakia

  • Fakultna nemocnica s poliklinikou F.D. Roosevelta

    RECRUITING

    Banská Bystrica, Slovakia

  • Fejer Varmegyei Szent Gyorgy Egyetemi Oktato Korhaz

    RECRUITING

    Székesfehérvár, Hungary

  • Fondazione IRCCS Policlinico San Matteo

    RECRUITING

    Pavia, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, Italy

  • Frontier Clinical Research, LLC

    RECRUITING

    Uniontown, Pennsylvania, 15401, United States

  • GCP Clinical Research, LLC

    RECRUITING

    Tampa, Florida, 33609, United States

  • GI Alliance

    RECRUITING

    Cedar Park, Texas, 78613, United States

  • GI Alliance - Garland

    NOT_YET_RECRUITING

    Garland, Texas, 75044, United States

  • GI Alliance - Gurnee

    NOT_YET_RECRUITING

    Mansfield, Texas, 76063, United States

  • GI Alliance -Gurnee

    RECRUITING

    Sun City, Arizona, 85351, United States

  • Gabinet Lekarski Bartosz Korczowski

    NOT_YET_RECRUITING

    Rzeszów, Poland

  • Gastro I, s.r.o.

    RECRUITING

    Prešov, Slovakia

  • Gastroenterology Consultants of Southwest Virginia.

    RECRUITING

    Roanoke, Virginia, 24014, United States

  • Gyongyosi Bugat Pal Korhaz

    NOT_YET_RECRUITING

    Gyöngyös, Hungary

  • Hamburgisches Forschungsinstitut fuer Chronisch Entzuendliche Darmerkrankungen

    RECRUITING

    Hamburg, Germany

  • Henry Ford Columbus Center

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Hepato-Gastroenterologie HK s.r.o.

    NOT_YET_RECRUITING

    Hradec Králové, Czechia

  • Hoag Hospital

    NOT_YET_RECRUITING

    Irvine, California, 92618, United States

  • Hopital Rangueil

    RECRUITING

    Toulouse, France

  • Hopital Saint Eloi

    RECRUITING

    Montpellier, France

  • Hopital Universitaire de Bruxelles - Hopital Erasme

    RECRUITING

    Brussels, Belgium

  • Hospital Clinico Universitario de Valencia

    NOT_YET_RECRUITING

    Valencia, Spain

  • Hospital General Juan Ramon Jimenez

    RECRUITING

    Huelva, Spain

  • Hospital Universitario Reina Sofia

    NOT_YET_RECRUITING

    Córdoba, Spain

  • Hospital Universitario Virgen del Rocio

    NOT_YET_RECRUITING

    Seville, Spain

  • Hospital Universitario de Fuenlabrada

    NOT_YET_RECRUITING

    Fuenlabrada, Spain

  • Hospital Universitario de Gran Canaria Dr. Negrin

    RECRUITING

    Las Palmas de Gran Canaria, Spain

  • Houston Methodist Hospital

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • Hôpital Bicêtre

    NOT_YET_RECRUITING

    Le Kremlin-Bicêtre, France

  • Hôpital Henri Mondor

    RECRUITING

    Créteil, France

  • Hôpital Nord - CHU Marseille

    NOT_YET_RECRUITING

    Marseille, France

  • Hôpital de Brabois

    NOT_YET_RECRUITING

    Vandœuvre-lès-Nancy, France

  • IMC Gulf Coast Gastroenterology, PC

    NOT_YET_RECRUITING

    Fairhope, Alabama, 36532, United States

  • IRCCS Ospedale Casa Sollievo della Sofferenza

    RECRUITING

    San Giovanni Rotondo, Italy

  • ISCARE a.s.

    NOT_YET_RECRUITING

    Prague, Czechia

  • Inquest Clinical Research

    NOT_YET_RECRUITING

    Baytown, Texas, 77521, United States

  • Institut des MICI

    RECRUITING

    Neuilly-sur-Seine, France

  • Istituto Clinico Humanitas

    RECRUITING

    Rozzano, Italy

  • KM Management spol. s r.o.

    RECRUITING

    Nitra, Slovakia

  • Kiepury Clinic MAŁGORZATA JARNOT SPECJALISTYCZNA PRAKTYKA GINEKOLOGICZNO-POŁOŻNICZA

    RECRUITING

    Sosnowiec, Poland

  • Krankenhaus Waldfriede e. V.

    RECRUITING

    Berlin, Germany

  • LMU - Campus Grosshadern

    NOT_YET_RECRUITING

    München, Germany

  • Lucida Clinical Trials, LLC

    RECRUITING

    New Bedford, Massachusetts, 02740, United States

  • Maastricht University Medical Center

    NOT_YET_RECRUITING

    Maastricht, Netherlands

  • Medical Network Spolka z o.o

    RECRUITING

    Warsaw, Poland

  • Medizinische Hochschule Hannover

    RECRUITING

    Hanover, Germany

  • Melita Medical Sp. Z O. O.

    RECRUITING

    Wroclaw, Poland

  • Mz Badania Slowik Zymla Sp J

    RECRUITING

    Knurów, Poland

  • NSZOZ Termedica - Centrum Badan Klinicznych

    NOT_YET_RECRUITING

    Poznan, Poland

  • NZOZ Centrum Medyczne KERmed

    NOT_YET_RECRUITING

    Bydgoszcz, Poland

  • NZOZ VIVAMED Jadwiga Miecz

    RECRUITING

    Warsaw, Poland

  • Nemocnice Slany

    RECRUITING

    Slaný, Czechia

  • Northwestern University

    RECRUITING

    Evanston, Illinois, 60208, United States

  • Novel Research, LLC

    RECRUITING

    Bellaire, Texas, 77401, United States

  • OSU Inflammatory Bowel Disease Center

    NOT_YET_RECRUITING

    Hilliard, Ohio, 43026, United States

  • Obudai Egeszsegugyi Centrum Kft.

    NOT_YET_RECRUITING

    Budapest, Hungary

  • Orlando Health, Inc.

    RECRUITING

    Orlando, Florida, 32806, United States

  • Ospedale Sacro Cuore Don Calabria

    NOT_YET_RECRUITING

    Negrar, Italy

  • Ospedale San Raffaele

    RECRUITING

    Milan, Italy

  • Pannonia Maganorvosi Centrum

    RECRUITING

    Budapest, Hungary

  • Peak Gastroenterology Associates

    RECRUITING

    Colorado Springs, Colorado, 80907, United States

  • Penta hospitals SK, a.s.

    RECRUITING

    Rimavská Sobota, Slovakia

  • PreventaMed s.r.o.

    RECRUITING

    Olomouc, Czechia

  • Radboud UMC

    NOT_YET_RECRUITING

    Nijmegen, Netherlands

  • Rapid City Medical Center, LLC

    RECRUITING

    Rapid City, South Dakota, 57701, United States

  • Research Associates of South Florida, LLC

    RECRUITING

    Miami, Florida, 33134, United States

  • Richmond VA Medical Center

    NOT_YET_RECRUITING

    Richmond, Virginia, 23249, United States

  • S.C Delta Health Care S.R.L

    RECRUITING

    Bucharest, Romania

  • S.C Pelican Impex S.R.L

    NOT_YET_RECRUITING

    Oradea, Romania

  • SC Centrul Medical Medicum SRL, Specialitatea Gastroenterologie

    RECRUITING

    Bucharest, Romania

  • SOLUMED Centrum Medyczne

    RECRUITING

    Poznan, Poland

  • Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lecznej

    RECRUITING

    Łęczna, Poland

  • Santa Sp. z o.o. Sp. K Polimedica PTG Kielce

    NOT_YET_RECRUITING

    Kielce, Poland

  • Sarkis Clinical Trials - Parent

    RECRUITING

    Ocala, Florida, 34474, United States

  • Scottsdale Gastroenterology Specialists

    NOT_YET_RECRUITING

    Scottsdale, Arizona, 85260, United States

  • Semmelweis Egyetem

    RECRUITING

    Budapest, Hungary

  • Semmelweis Egyetem

    NOT_YET_RECRUITING

    Budapest, Hungary

  • Southern Star Research Institute, LLC

    NOT_YET_RECRUITING

    San Antonio, Texas, 78229, United States

  • Spitalul Clinic Colentina

    NOT_YET_RECRUITING

    Bucharest, Romania

  • St. Marienkrankenhaus

    RECRUITING

    Ludwigshafen, Germany

  • SurGal Clinic s.r.o.

    RECRUITING

    Brno, Czechia

  • Susquehanna Research Group, LLC

    NOT_YET_RECRUITING

    Harrisburg, Pennsylvania, 17110, United States

  • Texas Digestive Specialists

    RECRUITING

    Harlingen, Texas, 78550, United States

  • Theia Clinical Research Centers, LLC

    RECRUITING

    Temple Terrace, Florida, 33617, United States

  • Trialmed CRS

    NOT_YET_RECRUITING

    Piotrkow Trybunalski, Poland

  • Twoja Przychodnia Opolskie Centrum Medyczne

    RECRUITING

    Opole, Poland

  • Twoja Przychodnia PCM

    RECRUITING

    Późna, Poland

  • Twoja Przychodnia-Szczecinskie Centrum Medyczne Sp. z o. o.

    RECRUITING

    Szczecin, Poland

  • Tyler Research Institute, LLC

    RECRUITING

    Tyler, Texas, 75701, United States

  • UPMC

    NOT_YET_RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • United Medical Doctors

    RECRUITING

    Murrieta, California, 92563, United States

  • Universitaetsklinikum Brandenburg an der Havel

    NOT_YET_RECRUITING

    Brandenburg an der Havel, Germany

  • Universitaetsklinikum Erlangen

    RECRUITING

    Erlangen, Germany

  • Universitaetsklinikum Frankfurt Goethe-Universitaet

    NOT_YET_RECRUITING

    Frankfurt am Main, Germany

  • Universitaetsklinikum Heidelberg

    NOT_YET_RECRUITING

    Heidelberg, Germany

  • Universitaetsklinikum Schleswig-Holstein - Campus Kiel

    RECRUITING

    Kiel, Germany

  • Universitaetsklinikum Ulm

    RECRUITING

    Ulm, Germany

  • Universitair Ziekenhuis Gent

    NOT_YET_RECRUITING

    Ghent, Belgium

  • University of Iowa Health Care

    NOT_YET_RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Massachusetts, Worcester

    NOT_YET_RECRUITING

    Worcester, Massachusetts, 01655, United States

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84108, United States

  • University of Washington

    NOT_YET_RECRUITING

    Seattle, Washington, 98195, United States

  • Università Campus Bio-Medico di Roma

    RECRUITING

    Roma, Italy

  • Valahia Medical SRL

    RECRUITING

    Ploieşti, Romania

  • Vanderbilt University Medical Center

    NOT_YET_RECRUITING

    Nashville, Tennessee, 37212, United States

  • Vojenska nemocnice Brno

    RECRUITING

    Brno, Czechia

  • Wellness Clinical Research

    NOT_YET_RECRUITING

    Miami Lakes, Florida, 33016, United States

  • West Central Gastroenterology d/b/a Gastro Florida

    RECRUITING

    Clearwater, Florida, 33762, United States